Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00636103

Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma

A Randomized Double-Blind Placebo-Controlled Study of the Effect of Traditional Chinese Medicines in the Treatment of Childhood Asthma

Sponsor: Chinese University of Hong Kong

Conditions Asthma

Interventions CUF2 Placebo

Updated 4 times since 2017 Last updated: Mar 11, 2008 Started: Jul 31, 2002 Primary completion: Aug 31, 2003 Completion: Aug 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Asthma, this trial is completed. The trial is conducted by Chinese University of Hong Kong and has accumulated 4 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

First recorded

Jul 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese University of Hong Kong
Tuen Mun Hospital
University Grants Committee, Hong Kong

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong